Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.-Reference-Cited by-同舟云学术

Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.

Published:1982-02-20 Issue:6315 Volume:284 Page:537-539
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Wenting G J,Man in 't Veld A J,Woittiez A J,Boomsma F,Schalekamp M A

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference12 articles.

1. Review of the role of the central serotonergic neuronal system in blood pressure regulation;Kuhn, D.M.; Wolf, W.A.; Lovenberg, W.;Hypertension,1980

2. Multiple serotonin receptors: differential binding of (3H)5-hydroxytryptamine, (3H)lysergic acid diethylamide and (3H) spiroperidol;Peroutka, S.J.; Snyder, S.;Molec Pharmacol,1979

3. Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors;Leysen, J.E.; Awouters, F.; Kennis, L.; Laduron, P.M.; Vandenberk, J.; Janssen, P.A.J.;Life Sci,1981

4. Vascular effects of R 41 468, a novel antagonist of 5-HT serotonergic receptors;JM, Van Nueten; PAJ, Janssen; J, Van Beek; R, Xhonneur; TJ, Verbeuren; PM, Vanhoutte;J Pharmacol Exp Ther,1981

5. Abnormal renal haemodynamics and renin suppression in hypertensive patients;Schalekamp, M.A.D.H.; Schalekamp-Kuyken, M.P.A.; Birkenhager, W.H.;Cli Sci,1970

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Series of 2,4(1H,3H)-Quinazolinedione Derivatives: Synthesis and Biological Evaluation as Potential Anticancer Agents;Letters in Drug Design & Discovery;2015-10-30

2. Serotonin and Blood Pressure Regulation;Pharmacological Reviews;2012-03-08

3. 5-Hydroxtryptamine Receptors in Systemic Hypertension: An Arterial Focus;Cardiovascular Therapeutics;2011-01-17

4. Ketanserin in Hypertension;Acta Medica Scandinavica;2009-04-24

5. Central 5-HT receptors in cardiovascular control during stress;Neuroscience & Biobehavioral Reviews;2009-02